A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

NCT03169894 ·Status: TERMINATED ·Phase: PHASE1

Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy

NCT00801125 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

NCT00707512 ·Status: TERMINATED

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

NCT04102111 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

NCT00306215 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

NCT00552344 ·Status: COMPLETED ·Phase: PHASE3

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

NCT01751152 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

NCT02394028 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

NCT02531113 ·Status: COMPLETED ·Phase: PHASE2

Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

NCT01224171 ·Status: COMPLETED ·Phase: PHASE3

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

NCT05688852 ·Status: TERMINATED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

NCT02403323 ·Status: TERMINATED ·Phase: PHASE3

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

NCT01150890 ·Status: TERMINATED ·Phase: PHASE2

A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease

NCT03681067 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

NCT00562887 ·Status: TERMINATED ·Phase: PHASE2

Monoclonal Antibody Treatment of Crohn's Disease

NCT00007163 ·Status: COMPLETED ·Phase: PHASE1

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating rhIL-11 in Active Crohn's Disease

NCT00040521 ·Status: COMPLETED ·Phase: PHASE2

Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

NCT00308581 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

NCT00584740 ·Status: TERMINATED ·Phase: PHASE2

CP-461 for the Treatment of Crohn's Disease

NCT00042055 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety Study of Brodalumab in Adults With Crohn's Disease

NCT01199302 ·Status: TERMINATED ·Phase: PHASE2